BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19142862)

  • 1. Transcriptional regulation of fibrillin-2 gene by E2F family members in chondrocyte differentiation.
    Yanagino T; Yuasa K; Nagahama M; Matsuda Y; Tsuji A
    J Cell Biochem; 2009 Mar; 106(4):580-8. PubMed ID: 19142862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
    Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
    Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
    Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
    Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha.
    Huang Z; Xu H; Sandell L
    J Bone Miner Res; 2004 Feb; 19(2):245-55. PubMed ID: 14969394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors.
    Itoh A; Levinson SF; Morita T; Kourembanas S; Brody JS; Mitsialis SA
    Cell Mol Biol Res; 1995; 41(3):147-54. PubMed ID: 8589754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.
    Goto Y; Hayashi R; Muramatsu T; Ogawa H; Eguchi I; Oshida Y; Ohtani K; Yoshida K
    Biochim Biophys Acta; 2006; 1759(1-2):60-8. PubMed ID: 16580749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
    Won J; Yim J; Kim TK
    FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctions in the specificity of E2F function revealed by gene expression signatures.
    Black EP; Hallstrom T; Dressman HK; West M; Nevins JR
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15948-53. PubMed ID: 16249342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
    Yuasa K; Suzue K; Nagahama M; Matsuda Y; Tsuji A
    Gene; 2007 Nov; 402(1-2):103-10. PubMed ID: 17825503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel fibrillin-2 mutations in congenital contractural arachnodactyly.
    Belleh S; Zhou G; Wang M; Der Kaloustian VM; Pagon RA; Godfrey M
    Am J Med Genet; 2000 May; 92(1):7-12. PubMed ID: 10797416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN; Pant V
    DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic values of
    Manicum T; Ni F; Ye Y; Fan X; Chen BC
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors.
    Parisi T; Pollice A; Di Cristofano A; CalabrĂ² V; La Mantia G
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1138-45. PubMed ID: 11883935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly.
    Putnam EA; Zhang H; Ramirez F; Milewicz DM
    Nat Genet; 1995 Dec; 11(4):456-8. PubMed ID: 7493032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
    Chapard C; Hohl D; Huber M
    Oncotarget; 2015 Aug; 6(25):20933-45. PubMed ID: 26369285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.